Reference : MONITORING METHOD FOR ADULT T-CELL LEUKEMIA/LYMPHOMA (ATL)
Patent : Patent
Human health sciences : Immunology & infectious disease
http://hdl.handle.net/2268/231040
MONITORING METHOD FOR ADULT T-CELL LEUKEMIA/LYMPHOMA (ATL)
English
Georges, Michel mailto [Université de Liège - ULiège > > Unit of Animal Genomics >]
Van den Broeke, Anne mailto [Institut Jules Bordet, Université Libre de Bruxelles (ULB) > Laboratory of Experimental Hematology > > >]
Durkin, Keith mailto [Université de Liège - ULiège > > Unit of Animal Genomics >]
Artesi, Maria mailto [Université de Liège - ULiège > > GIGA-Research >]
Hahaut, Vincent mailto [Université de Liège - ULiège > Dpt. de gestion vétérinaire des Ressources Animales (DRA) > GIGA-R : Génomique animale >]
Rosewick, Nicolas [Institut Jules Bordet, Université Libre de Bruxelles (ULB) > > Laboratory of Experimental Hematology > > >]
11-Oct-2018
2017-04-06
World Intellectual Property Organization
WO 2018/184683 Al
PCT/EP2017/058271
none
Europe
UNIVERSITE DE LIEGE, INSTITUT JULES BORDET, UNIVERSITE LIBRE DE BRUXELLES
C12Q 1/68 (2006 .0 1) C12Q 1/70 (2006 .01)
C12Q1/6806; C12Q1/702
AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY,TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
[en] HTLV-1 ; Retrovirus ; cancer
[en] The present invention refers to a method for preparing a linear PCR product from genomic DNA derived from cells of
a host subject infected with an retrovirus or a subject suffering from a disease associated with said retrovirus, wherein the PCR product
contains a target sequence comprising an integration site of the retrovirus in the host genomic DNA of the cells, said integration site
comprising at least the terminal end of 3'-LTR or 5'-LTR sequence of the retrovirus and the adjacent host genomic DNA sequence,
wherein the PCR product comprises a first terminus and a second terminus and sequences in the following order: sequences specific for
the first terminus, a sequence comprising at least6 consecutive random nucleotides followed by a linker sequence, host genomic DNA
sequence, at least the terminal endof 3'-LTR or 5' -LTR sequence of the retrovirus, sequences specific for the second terminus; wherein
the PCR product is prepared by specific steps. The present invention also refers to a method for determining and longitudinally monitor
the dominant leukemic T lymphocyte clone in subjects suffering from Adult T-cell leukemia/lymphoma (ATL), wherein a linear PCR
product is prepared by the method according to the first aspect of the present invention, said PCR product is subjected to multiplex
sequencing thereby determining all insertion sites and all shearing sites, the shearing sites are correlated to the respective insertion site,
followed by counting the number of different shear sites for each insertion site representing a specific T lymphocyte clone, removing
any PCR duplicate from consideration by eliminating reads that have the same insertion site and the same random tag, and determining
the abundance of each specific T lymphocyte clone therefrom.
Giga-Genetics
http://hdl.handle.net/2268/231040

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
WO2018184683A1.pdfAuthor postprint1.41 MBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.